These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30177073)

  • 21. Maternal and fetal outcome in women with hypertensive disorders of pregnancy: the impact of prenatal care.
    Barbosa IR; Silva WB; Cerqueira GS; Novo NF; Almeida FA; Novo JL
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):140-6. PubMed ID: 26220808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported maternal morbidity: Results from the community level interventions for pre-eclampsia (CLIP) baseline survey in Sindh, Pakistan.
    Sheikh S; Qureshi RN; Raza F; Memon J; Ahmed I; Vidler M; Payne BA; Lee T; Sawchuck D; Magee L; von Dadelszen P; Bhutta Z;
    Pregnancy Hypertens; 2019 Jul; 17():113-120. PubMed ID: 31487626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of Community Level Interventions for Pre-eclampsia (CLIP) in South Asian and African countries: a study protocol.
    Khowaja AR; Mitton C; Bryan S; Magee LA; Bhutta ZA; von Dadelszen P
    Implement Sci; 2015 May; 10():76. PubMed ID: 26007682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scientific basis for the content of routine antenatal care. I. Philosophy, recent studies, and power to eliminate or alleviate adverse maternal outcomes.
    Villar J; Bergsjø P
    Acta Obstet Gynecol Scand; 1997 Jan; 76(1):1-14. PubMed ID: 9033238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quality of care to prevent and treat postpartum hemorrhage and pre-eclampsia/eclampsia : an observational assessment in Madagascar's hospitals].
    Bazant E; Rakotovao JP; Rasolofomanana JR; Tripathi V; Gomez P; Favero R; Moffson S
    Med Sante Trop; 2013 May; 23(2):168-75. PubMed ID: 23694783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation.
    Gallo DM; Wright D; Casanova C; Campanero M; Nicolaides KH
    Am J Obstet Gynecol; 2016 May; 214(5):619.e1-619.e17. PubMed ID: 26627730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.
    Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia.
    Tsiakkas A; Mendez O; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Apr; 47(4):478-83. PubMed ID: 26582564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.
    Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P
    Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal death in the booked and unbooked patients: University of Port Harcourt Teaching Hospital experience.
    Briggs ND
    Trop J Obstet Gynaecol; 1988; 1(1):26-9. PubMed ID: 12179272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study protocol: establishment of a multicentre pre-eclampsia database and biobank in Sweden: GO PROVE and UP MOST, a prospective cohort study.
    Thorgeirsdottir L; Andersson M; Karlsson O; Thörn SE; Oras J; Sengpiel V; Svanvik T; Elden H; Linden K; Junus K; Lager S; Enskär I; van Veen T; Wikström J; Björkman-Burtscher I; Stigsdotter Neely A; Wikström AK; Bergman L
    BMJ Open; 2021 Nov; 11(11):e049559. PubMed ID: 34819281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation.
    Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guinea-Bissau: maternal mortality assessment.
    Oosterbaan MM
    World Health Stat Q; 1995; 48(1):34-8. PubMed ID: 7571708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women.
    Keikkala E; Forstén J; Ritvos O; Stenman UH; Kajantie E; Hämäläinen E; Räikkönen K; Villa PM; Laivuori H
    Pregnancy Hypertens; 2021 Aug; 25():116-122. PubMed ID: 34116346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: A retrospective cohort study.
    Ndwiga C; Odwe G; Pooja S; Ogutu O; Osoti A; E Warren C
    PLoS One; 2020; 15(6):e0233323. PubMed ID: 32502144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does antenatal care make a difference to safe delivery? A study in urban Uttar Pradesh, India.
    Bloom SS; Lippeveld T; Wypij D
    Health Policy Plan; 1999 Mar; 14(1):38-48. PubMed ID: 10351468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.